ArticleCommunications biology2025
TORC2 inactivation promotes heterochromatin formation in rDNA and prolongs viability of quiescent fission yeast cells.
Article in Communications biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
A large amount of the energy produced by glucose is consumed in the biogenesis of ribosomes, the cellular machinery for protein synthesis. Recent studies suggest that a low-calorie diet and the suppression of ribosome biogenesis can extend lifespan. However, the molecular mechanisms underlying these phenomena remain elusive. Here, we demonstrate that TORC2 (TOR complex 2) promotes ribosomal RNA (rRNA) transcription by facilitating the association of Paf1C (RNA polymerase II-associated factor 1 complex) with the rDNA region. Under glucose starvation, inactivation of the TORC2-Gad8 pathway leads to the dissociation of Paf1C from rDNA, thereby promoting heterochromatin formation and transcriptional repression. This mechanism is distinct from TORC1-mediated gene regulation of rDNA. Additionally, simultaneous inactivation of the redundant TORC1 and TORC2 pathways in nutrient-rich conditions leads to robust rDNA heterochromatin formation and rRNA transcriptional suppression, which is associated with prolonged viability of quiescent cells. This extension of viability is attenuated by the disruption of the H3K9 methyltransferase Clr4. These results suggest that robust heterochromatin formation in the rDNA region may support sustained survival of quiescent cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.